Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Office of Crisis Management

Executive Summary

FDA Office of Emergency Operations Director Ellen Morrison named as first Office of Crisis Management director. FDA Deputy Commissioner Lester Crawford has been acting crisis management director since the office's inception in October 2002 (1"The Pink Sheet" Oct. 21, 2002, p. 15). FDA also said it is "in the process of selecting" a counter-terrorism policy director, who will be in the Office of Policy...

You may also be interested in...



FDA Crisis Management Office To Streamline Counterterrorism Response

FDA Deputy Commissioner Lester Crawford will streamline the agency's counterterrorism efforts as the head of the FDA Office of Crisis Management

Probiotics And Cold Remedies Boost Recordati In 2023

Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.

Falling Sales Force New Priorities At Roche

The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS041564

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel